Industry efforts to do away with the Patent Trial and Appeals Board (PTAB) process were thwarted on 21 June when a divided Supreme Court issued rulings in high-profile patent case US v. Arthrex that leave the process largely in place, but order the Patent and Trademark Office (PTO) to give the office’s director greater oversight of rulings.
The justices split 5-4 on whether the process, established under the 2012 America Invents Act, was constitutional, and 7-2 on whether giving the director more authority would fix the issues
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?